Tyzeka Related Clinical Trials
Efficacy and Safety of Telbivudine in Treatment naïve Patients With HBeAg-Positive Chronic Hepatitis B (CHB) [Terminated]
Telbivudine Versus the Combination of Telbivudine and Valtorcitabine in Patients With Chronic Hepatitis B [Active, not recruiting]
An Extension to Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B [Recruiting]
Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine Studies [Active, not recruiting]
Trial of Telbivudine Combination Therapy vs. Continued Adefovir Monotherapy [Withdrawn]
Prospective Exploratory Study to Evaluate the Safety and Efficacy of Telbivudine in the Fifth Year of Treatment in Chinese Patients With Compensated Chronic Hepatitis B [Recruiting]
A Single-Arm Study Evaluating the Efficacy and Safety of Telbivudine With or Without Add-on Tenofovir in Adults With HBeAg-Positive Chronic Hepatitis B (CHB) [Recruiting]
Prospective Exploratory Study to Describe Hepatitis B Virus (HBV) Kinetics During Treatment With Telbivudine [Recruiting]
Comparison of Telbivudine Versus Lamivudine on the Early Dynamics and Kinetics of Viral Suppression in Chronic Hepatitis B [Not yet recruiting]
An Extension Study of Telbivudine, Lamivudine or Telbivudine Plus Lamivudine in Patients With Chronic Hepatitis B [Completed]
Effects of Telbivudine and Tenofovir Disproxil Fumarate on the Kinetics of Hepatitis B Virus DNA in Chronic Hepatitis B (CHB) [Not yet recruiting]
Effects of Telbivudine and Tenofovir Disoproxil Fumarate Treatment on the Hepatitis B Virus DNA Kinetics in CHB [Recruiting]
To Evaluate Antiviral Efficacy of Telbivudine in Hepatitis B Antigen Positive (HbeAg-positive) Compensated Chronic Hepatitis B (CHB) [Recruiting]
Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B [Active, not recruiting]
EFFicacy Optimization Research of Telbivudine Therapy [Recruiting]
Switching Therapy From Lamivudine to Telbivudine Versus Continued Lamivudine in Adults With Chronic Hepatitis B [Completed]
Efficacy of Telbivudine Treatment at Long Term on the Absence of Liver Inflammation in Patients With Compensated Chronic Hepatitis B [Recruiting]
Efficacy and Safety of Telbivudine 600mg Tablets in Chinese Patients With Chronic Hepatitis B [Recruiting]
Telbivudine Versus Lamivudine in Chinese Adults With Compensated Chronic Hepatitis B [Completed]
Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis [Active, not recruiting]
Efficacy and Safety of Telbivudine in Patients With Chronic Hepatitis B [Terminated]
Telbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive, Compensated Chronic Hepatitis B [Completed]
A Randomized, Double Blind Trial of LdT (Telbivudine) Versus Lamivudine in Adults With Compensated Chronic Hepatitis B [Completed]
A Comparison of the Drug Telbivudine (LdT) and Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis. [Completed]
Study of Combination Therapy With LdT Plus Adefovir Versus Adefovir Alone [Recruiting]
Pharmacokinetics and Safety of Single-Dose Telbivudine in Children and Adolescents With Chronic Hepatitis B [Recruiting]
Treatment of Hepatitis B Virus (HBV) Before Beginning Anti-HIV Drugs in Patients With Both HBV and HIV [Active, not recruiting]
Efficacy of Telbivudine in Blacks/African Americans and Hispanics/Latinos With Compensated Chronic Hepatitis B During 52 Weeks [Recruiting]
Prednisolone Priming Study in Patients With Chronic Hepatitis B [Recruiting]
Influence of Antiviral Treatment to the Long-Term Prognosis of Patients With Chronic HBV Infection [Recruiting]
Tenofovir Alone Versus Tenofovir With Emtricitabine to Treat Chronic Hepatitis B [Recruiting]
|
